跳至主要内容
临床试验/IRCT20231119060108N1
IRCT20231119060108N1招募中2 期

Safety and Efficacy of Rituximab in patients with juvenile dermatomyositis (JDM) who were admitted at Mofid children hospital

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 7 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
7

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 16 years(—)
性别
All

入选标准

  • Patient under 16 years old
  • Patients with the diagnosis of dermatomyositis, which is confirmed based on the diagnosis criteria

排除标准

  • Presence of concomitant diseases and overlap syndrome
  • Contraindications for rituximab injection

研究者

相似试验

进行中(未招募)
不适用
Efficacy and safety of rituximab in patients with rheumatoid arthritis - FIRSTMedDRA version: 8.1Level: PTClassification code 10039073Term: Rheumatoid arthritisRheumatoid arthritis
EUCTR2006-001000-37-DERoche Pharma AG300
进行中(未招募)
不适用
Efficacy of Rituximab treatment in patients with rheumatoid arthritis having inadequate response to TNF blockerTo investigate the efficacy of treatment with Rituximab (MabThera®) in patients with active RA whose current treatment with one or more TNF-blocker (Etanercept - Enbrel®, Infliximab – Remicade® or Adalimumab - Humira®) alone or in combination with MTX is insufficient measured by DAS28 activity index.
EUCTR2006-004673-98-HURoche (Hungary) Ltd.20
已完成
不适用
Efficacy and safety of rituximab for patients with severe rheumatic diseaseChildhood-onset severe rheumatic disease (systemic lupus erhythematosus, dermatomyositis, poly myositis, systemic sclerosis , mixed connective tissue disease, Sjogren&#39s syndrome, anti-phospholipid syndrome)
JPRN-UMIN000018376Yokohama City University Hospital Department of Pediatrics20
已完成
2 期
The Evaluation of Efficacy and Safety of Rituximab (Genetical Recombination) in Refractory Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Patients with Immunoglobulin G4 (IgG4) Autoantibodies in the Exploratory Clinical TrialChronic Inflammatory Demyelinating Polyneuropathy
JPRN-UMIN000035753agoya University Hospital27
已完成
2 期
RECIPE TrialChronic Inflammatory Demyelinating Polyneuropathy
JPRN-jRCT2041180037Iijima Masahiro25